These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

773 related articles for article (PubMed ID: 26555211)

  • 1. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
    Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
    Prion; 2015; 9(5):394-403. PubMed ID: 26555211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
    Kim DH; Lee HM; Ryou C
    J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
    Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
    Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrPSc Species.
    Mays CE; van der Merwe J; Kim C; Haldiman T; McKenzie D; Safar JG; Westaway D
    J Virol; 2015 Dec; 89(24):12418-26. PubMed ID: 26423957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion infectivity is encoded exclusively within the structure of proteinase K-resistant fragments of synthetically generated recombinant PrP
    Wang F; Wang X; Abskharon R; Ma J
    Acta Neuropathol Commun; 2018 Apr; 6(1):30. PubMed ID: 29699569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
    J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods.
    Shaked GM; Meiner Z; Avraham I; Taraboulos A; Gabizon R
    J Biol Chem; 2001 Apr; 276(17):14324-8. PubMed ID: 11152454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quaternary structure of pathological prion protein as a determining factor of strain-specific prion replication dynamics.
    Laferrière F; Tixador P; Moudjou M; Chapuis J; Sibille P; Herzog L; Reine F; Jaumain E; Laude H; Rezaei H; Béringue V
    PLoS Pathog; 2013; 9(10):e1003702. PubMed ID: 24130496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases.
    Imberdis T; Ayrolles-Torro A; Duarte Rodrigues A; Torrent J; Alvarez-Martinez MT; Kovacs GG; Verdier JM; Robitzer M; Perrier V
    Mol Neurodegener; 2016 Jan; 11():11. PubMed ID: 26809712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of SMB-S15 Cells with Resveratrol Efficiently Removes the PrP(Sc) Accumulation In Vitro and Prion Infectivity In Vivo.
    Wang J; Zhang BY; Zhang J; Xiao K; Chen LN; Wang H; Sun J; Shi Q; Dong XP
    Mol Neurobiol; 2016 Oct; 53(8):5367-76. PubMed ID: 26440667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical Characterization of Prions.
    Fiorini M; Bongianni M; Monaco S; Zanusso G
    Prog Mol Biol Transl Sci; 2017; 150():389-407. PubMed ID: 28838671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion formation, but not clearance, is supported by protein misfolding cyclic amplification.
    Shikiya RA; Eckland TE; Young AJ; Bartz JC
    Prion; 2014; 8(6):415-20. PubMed ID: 25482601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow Cytometric Detection of PrP
    Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crossing Species Barriers Relies on Structurally Distinct Prion Assemblies and Their Complementation.
    Igel-Egalon A; Laferrière F; Tixador P; Moudjou M; Herzog L; Reine F; Torres JM; Laude H; Rezaei H; Béringue V
    Mol Neurobiol; 2020 Jun; 57(6):2572-2587. PubMed ID: 32239450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of disease-associated prion protein to plasminogen.
    Fischer MB; Roeckl C; Parizek P; Schwarz HP; Aguzzi A
    Nature; 2000 Nov; 408(6811):479-83. PubMed ID: 11100730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions.
    Saverioni D; Notari S; Capellari S; Poggiolini I; Giese A; Kretzschmar HA; Parchi P
    J Biol Chem; 2013 Sep; 288(39):27972-85. PubMed ID: 23897825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prion's elusive reason for being.
    Aguzzi A; Baumann F; Bremer J
    Annu Rev Neurosci; 2008; 31():439-77. PubMed ID: 18558863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prions in skeletal muscle.
    Bosque PJ; Ryou C; Telling G; Peretz D; Legname G; DeArmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3812-7. PubMed ID: 11904434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.